0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Drug Eluting Implant - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-6X5138
Home | Market Reports | Health| Health Foundations & Medical Research
Global Drug Eluting Implant Market Insights Forecast to 2028
BUY CHAPTERS

Drug Eluting Implant - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-6X5138
Report
November 2024
Pages:146
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Eluting Implant - Market Size

The global market for Drug Eluting Implant was estimated to be worth US$ 6855 million in 2023 and is forecast to a readjusted size of US$ 10480 million by 2030 with a CAGR of 6.6% during the forecast period 2024-2030

Drug Eluting Implant - Market

Drug Eluting Implant - Market

Drug eluting implants encompass a wide range of bioactive implants that can be placed in or near a tissue to provide a controlled, sustained or on demand release of drug while overcoming barriers associated with traditional oral and intravenous drug administration, such as limited bioavailability, metabolism, and toxicity.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Eluting Implant, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Drug Eluting Implant by region & country, by Type, and by Application.
The Drug Eluting Implant market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Implant.
Market Segmentation

Scope of Drug Eluting Implant - Market Report

Report Metric Details
Report Name Drug Eluting Implant - Market
Forecasted market size in 2030 US$ 10480 million
CAGR 6.6%
Forecasted years 2024 - 2030
Segment by Type:
  • Rapamycin Eluting Implant
  • Paclitaxel Eluting Implant
  • Everolimus Eluting Implant
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boston Scientific, Medtronic, Abbott, Lepu Medical, B. Braun Melsungen, MicroPort Scientific, Cook Medical, Terumo, Biosensors International, Balton, AlviMedica Medical Technologies, Biotronik, Shandong JW Medical, Sino Medical, Beijing AMSINO
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Drug Eluting Implant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Drug Eluting Implant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Drug Eluting Implant in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Drug Eluting Implant - Market size in 2030?

Ans: The Drug Eluting Implant - Market size in 2030 will be US$ 10480 million.

Who are the main players in the Drug Eluting Implant - Market report?

Ans: The main players in the Drug Eluting Implant - Market are Boston Scientific, Medtronic, Abbott, Lepu Medical, B. Braun Melsungen, MicroPort Scientific, Cook Medical, Terumo, Biosensors International, Balton, AlviMedica Medical Technologies, Biotronik, Shandong JW Medical, Sino Medical, Beijing AMSINO

What are the Application segmentation covered in the Drug Eluting Implant - Market report?

Ans: The Applications covered in the Drug Eluting Implant - Market report are Hospitals, Clinics, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Drug Eluting Implant - Market report?

Ans: The Types covered in the Drug Eluting Implant - Market report are Rapamycin Eluting Implant, Paclitaxel Eluting Implant, Everolimus Eluting Implant, Others

1 Market Overview
1.1 Drug Eluting Implant Product Introduction
1.2 Global Drug Eluting Implant Market Size Forecast
1.2.1 Global Drug Eluting Implant Sales Value (2019-2030)
1.2.2 Global Drug Eluting Implant Sales Volume (2019-2030)
1.2.3 Global Drug Eluting Implant Sales Price (2019-2030)
1.3 Drug Eluting Implant Market Trends & Drivers
1.3.1 Drug Eluting Implant Industry Trends
1.3.2 Drug Eluting Implant Market Drivers & Opportunity
1.3.3 Drug Eluting Implant Market Challenges
1.3.4 Drug Eluting Implant Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drug Eluting Implant Players Revenue Ranking (2023)
2.2 Global Drug Eluting Implant Revenue by Company (2019-2024)
2.3 Global Drug Eluting Implant Players Sales Volume Ranking (2023)
2.4 Global Drug Eluting Implant Sales Volume by Company Players (2019-2024)
2.5 Global Drug Eluting Implant Average Price by Company (2019-2024)
2.6 Key Manufacturers Drug Eluting Implant Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Drug Eluting Implant Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Drug Eluting Implant
2.9 Drug Eluting Implant Market Competitive Analysis
2.9.1 Drug Eluting Implant Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Drug Eluting Implant Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Implant as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Rapamycin Eluting Implant
3.1.2 Paclitaxel Eluting Implant
3.1.3 Everolimus Eluting Implant
3.1.4 Others
3.2 Global Drug Eluting Implant Sales Value by Type
3.2.1 Global Drug Eluting Implant Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drug Eluting Implant Sales Value, by Type (2019-2030)
3.2.3 Global Drug Eluting Implant Sales Value, by Type (%) (2019-2030)
3.3 Global Drug Eluting Implant Sales Volume by Type
3.3.1 Global Drug Eluting Implant Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Drug Eluting Implant Sales Volume, by Type (2019-2030)
3.3.3 Global Drug Eluting Implant Sales Volume, by Type (%) (2019-2030)
3.4 Global Drug Eluting Implant Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Ambulatory Surgical Centers
4.1.4 Others
4.2 Global Drug Eluting Implant Sales Value by Application
4.2.1 Global Drug Eluting Implant Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drug Eluting Implant Sales Value, by Application (2019-2030)
4.2.3 Global Drug Eluting Implant Sales Value, by Application (%) (2019-2030)
4.3 Global Drug Eluting Implant Sales Volume by Application
4.3.1 Global Drug Eluting Implant Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Drug Eluting Implant Sales Volume, by Application (2019-2030)
4.3.3 Global Drug Eluting Implant Sales Volume, by Application (%) (2019-2030)
4.4 Global Drug Eluting Implant Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Drug Eluting Implant Sales Value by Region
5.1.1 Global Drug Eluting Implant Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drug Eluting Implant Sales Value by Region (2019-2024)
5.1.3 Global Drug Eluting Implant Sales Value by Region (2025-2030)
5.1.4 Global Drug Eluting Implant Sales Value by Region (%), (2019-2030)
5.2 Global Drug Eluting Implant Sales Volume by Region
5.2.1 Global Drug Eluting Implant Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Drug Eluting Implant Sales Volume by Region (2019-2024)
5.2.3 Global Drug Eluting Implant Sales Volume by Region (2025-2030)
5.2.4 Global Drug Eluting Implant Sales Volume by Region (%), (2019-2030)
5.3 Global Drug Eluting Implant Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Drug Eluting Implant Sales Value, 2019-2030
5.4.2 North America Drug Eluting Implant Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Drug Eluting Implant Sales Value, 2019-2030
5.5.2 Europe Drug Eluting Implant Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Drug Eluting Implant Sales Value, 2019-2030
5.6.2 Asia Pacific Drug Eluting Implant Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Drug Eluting Implant Sales Value, 2019-2030
5.7.2 South America Drug Eluting Implant Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Drug Eluting Implant Sales Value, 2019-2030
5.8.2 Middle East & Africa Drug Eluting Implant Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drug Eluting Implant Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drug Eluting Implant Sales Value
6.2.1 Key Countries/Regions Drug Eluting Implant Sales Value, 2019-2030
6.2.2 Key Countries/Regions Drug Eluting Implant Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Drug Eluting Implant Sales Value, 2019-2030
6.3.2 United States Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drug Eluting Implant Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drug Eluting Implant Sales Value, 2019-2030
6.4.2 Europe Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drug Eluting Implant Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drug Eluting Implant Sales Value, 2019-2030
6.5.2 China Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drug Eluting Implant Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drug Eluting Implant Sales Value, 2019-2030
6.6.2 Japan Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drug Eluting Implant Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drug Eluting Implant Sales Value, 2019-2030
6.7.2 South Korea Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drug Eluting Implant Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drug Eluting Implant Sales Value, 2019-2030
6.8.2 Southeast Asia Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drug Eluting Implant Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drug Eluting Implant Sales Value, 2019-2030
6.9.2 India Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drug Eluting Implant Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Company Information
7.1.2 Boston Scientific Introduction and Business Overview
7.1.3 Boston Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Boston Scientific Drug Eluting Implant Product Offerings
7.1.5 Boston Scientific Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Introduction and Business Overview
7.2.3 Medtronic Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Medtronic Drug Eluting Implant Product Offerings
7.2.5 Medtronic Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Introduction and Business Overview
7.3.3 Abbott Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Abbott Drug Eluting Implant Product Offerings
7.3.5 Abbott Recent Development
7.4 Lepu Medical
7.4.1 Lepu Medical Company Information
7.4.2 Lepu Medical Introduction and Business Overview
7.4.3 Lepu Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Lepu Medical Drug Eluting Implant Product Offerings
7.4.5 Lepu Medical Recent Development
7.5 B. Braun Melsungen
7.5.1 B. Braun Melsungen Company Information
7.5.2 B. Braun Melsungen Introduction and Business Overview
7.5.3 B. Braun Melsungen Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.5.4 B. Braun Melsungen Drug Eluting Implant Product Offerings
7.5.5 B. Braun Melsungen Recent Development
7.6 MicroPort Scientific
7.6.1 MicroPort Scientific Company Information
7.6.2 MicroPort Scientific Introduction and Business Overview
7.6.3 MicroPort Scientific Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.6.4 MicroPort Scientific Drug Eluting Implant Product Offerings
7.6.5 MicroPort Scientific Recent Development
7.7 Cook Medical
7.7.1 Cook Medical Company Information
7.7.2 Cook Medical Introduction and Business Overview
7.7.3 Cook Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Cook Medical Drug Eluting Implant Product Offerings
7.7.5 Cook Medical Recent Development
7.8 Terumo
7.8.1 Terumo Company Information
7.8.2 Terumo Introduction and Business Overview
7.8.3 Terumo Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Terumo Drug Eluting Implant Product Offerings
7.8.5 Terumo Recent Development
7.9 Biosensors International
7.9.1 Biosensors International Company Information
7.9.2 Biosensors International Introduction and Business Overview
7.9.3 Biosensors International Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Biosensors International Drug Eluting Implant Product Offerings
7.9.5 Biosensors International Recent Development
7.10 Balton
7.10.1 Balton Company Information
7.10.2 Balton Introduction and Business Overview
7.10.3 Balton Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Balton Drug Eluting Implant Product Offerings
7.10.5 Balton Recent Development
7.11 AlviMedica Medical Technologies
7.11.1 AlviMedica Medical Technologies Company Information
7.11.2 AlviMedica Medical Technologies Introduction and Business Overview
7.11.3 AlviMedica Medical Technologies Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.11.4 AlviMedica Medical Technologies Drug Eluting Implant Product Offerings
7.11.5 AlviMedica Medical Technologies Recent Development
7.12 Biotronik
7.12.1 Biotronik Company Information
7.12.2 Biotronik Introduction and Business Overview
7.12.3 Biotronik Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Biotronik Drug Eluting Implant Product Offerings
7.12.5 Biotronik Recent Development
7.13 Shandong JW Medical
7.13.1 Shandong JW Medical Company Information
7.13.2 Shandong JW Medical Introduction and Business Overview
7.13.3 Shandong JW Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Shandong JW Medical Drug Eluting Implant Product Offerings
7.13.5 Shandong JW Medical Recent Development
7.14 Sino Medical
7.14.1 Sino Medical Company Information
7.14.2 Sino Medical Introduction and Business Overview
7.14.3 Sino Medical Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Sino Medical Drug Eluting Implant Product Offerings
7.14.5 Sino Medical Recent Development
7.15 Beijing AMSINO
7.15.1 Beijing AMSINO Company Information
7.15.2 Beijing AMSINO Introduction and Business Overview
7.15.3 Beijing AMSINO Drug Eluting Implant Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Beijing AMSINO Drug Eluting Implant Product Offerings
7.15.5 Beijing AMSINO Recent Development
8 Industry Chain Analysis
8.1 Drug Eluting Implant Industrial Chain
8.2 Drug Eluting Implant Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drug Eluting Implant Sales Model
8.5.2 Sales Channel
8.5.3 Drug Eluting Implant Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Drug Eluting Implant Market Trends
    Table 2. Drug Eluting Implant Market Drivers & Opportunity
    Table 3. Drug Eluting Implant Market Challenges
    Table 4. Drug Eluting Implant Market Restraints
    Table 5. Global Drug Eluting Implant Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Drug Eluting Implant Revenue Market Share by Company (2019-2024)
    Table 7. Global Drug Eluting Implant Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Drug Eluting Implant Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Drug Eluting Implant Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Drug Eluting Implant Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Drug Eluting Implant Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Drug Eluting Implant
    Table 13. Global Drug Eluting Implant Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Implant as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Drug Eluting Implant Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Drug Eluting Implant Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Drug Eluting Implant Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Drug Eluting Implant Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Drug Eluting Implant Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Drug Eluting Implant Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Drug Eluting Implant Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Drug Eluting Implant Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Drug Eluting Implant Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Drug Eluting Implant Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Drug Eluting Implant Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Drug Eluting Implant Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Drug Eluting Implant Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Drug Eluting Implant Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Drug Eluting Implant Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Drug Eluting Implant Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Drug Eluting Implant Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Drug Eluting Implant Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Drug Eluting Implant Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Drug Eluting Implant Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Drug Eluting Implant Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Drug Eluting Implant Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Drug Eluting Implant Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Drug Eluting Implant Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Drug Eluting Implant Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Drug Eluting Implant Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Drug Eluting Implant Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Drug Eluting Implant Sales Value by Region (2019-2024) & (%)
    Table 44. Global Drug Eluting Implant Sales Value by Region (2025-2030) & (%)
    Table 45. Global Drug Eluting Implant Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Drug Eluting Implant Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Drug Eluting Implant Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Drug Eluting Implant Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Drug Eluting Implant Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Drug Eluting Implant Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Drug Eluting Implant Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Drug Eluting Implant Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Drug Eluting Implant Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Drug Eluting Implant Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Drug Eluting Implant Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Drug Eluting Implant Sales Volume, (2025-2030) & (K Units)
    Table 57. Boston Scientific Company Information
    Table 58. Boston Scientific Introduction and Business Overview
    Table 59. Boston Scientific Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Boston Scientific Drug Eluting Implant Product Offerings
    Table 61. Boston Scientific Recent Development
    Table 62. Medtronic Company Information
    Table 63. Medtronic Introduction and Business Overview
    Table 64. Medtronic Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Medtronic Drug Eluting Implant Product Offerings
    Table 66. Medtronic Recent Development
    Table 67. Abbott Company Information
    Table 68. Abbott Introduction and Business Overview
    Table 69. Abbott Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Abbott Drug Eluting Implant Product Offerings
    Table 71. Abbott Recent Development
    Table 72. Lepu Medical Company Information
    Table 73. Lepu Medical Introduction and Business Overview
    Table 74. Lepu Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Lepu Medical Drug Eluting Implant Product Offerings
    Table 76. Lepu Medical Recent Development
    Table 77. B. Braun Melsungen Company Information
    Table 78. B. Braun Melsungen Introduction and Business Overview
    Table 79. B. Braun Melsungen Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. B. Braun Melsungen Drug Eluting Implant Product Offerings
    Table 81. B. Braun Melsungen Recent Development
    Table 82. MicroPort Scientific Company Information
    Table 83. MicroPort Scientific Introduction and Business Overview
    Table 84. MicroPort Scientific Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. MicroPort Scientific Drug Eluting Implant Product Offerings
    Table 86. MicroPort Scientific Recent Development
    Table 87. Cook Medical Company Information
    Table 88. Cook Medical Introduction and Business Overview
    Table 89. Cook Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Cook Medical Drug Eluting Implant Product Offerings
    Table 91. Cook Medical Recent Development
    Table 92. Terumo Company Information
    Table 93. Terumo Introduction and Business Overview
    Table 94. Terumo Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Terumo Drug Eluting Implant Product Offerings
    Table 96. Terumo Recent Development
    Table 97. Biosensors International Company Information
    Table 98. Biosensors International Introduction and Business Overview
    Table 99. Biosensors International Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Biosensors International Drug Eluting Implant Product Offerings
    Table 101. Biosensors International Recent Development
    Table 102. Balton Company Information
    Table 103. Balton Introduction and Business Overview
    Table 104. Balton Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Balton Drug Eluting Implant Product Offerings
    Table 106. Balton Recent Development
    Table 107. AlviMedica Medical Technologies Company Information
    Table 108. AlviMedica Medical Technologies Introduction and Business Overview
    Table 109. AlviMedica Medical Technologies Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. AlviMedica Medical Technologies Drug Eluting Implant Product Offerings
    Table 111. AlviMedica Medical Technologies Recent Development
    Table 112. Biotronik Company Information
    Table 113. Biotronik Introduction and Business Overview
    Table 114. Biotronik Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Biotronik Drug Eluting Implant Product Offerings
    Table 116. Biotronik Recent Development
    Table 117. Shandong JW Medical Company Information
    Table 118. Shandong JW Medical Introduction and Business Overview
    Table 119. Shandong JW Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Shandong JW Medical Drug Eluting Implant Product Offerings
    Table 121. Shandong JW Medical Recent Development
    Table 122. Sino Medical Company Information
    Table 123. Sino Medical Introduction and Business Overview
    Table 124. Sino Medical Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Sino Medical Drug Eluting Implant Product Offerings
    Table 126. Sino Medical Recent Development
    Table 127. Beijing AMSINO Company Information
    Table 128. Beijing AMSINO Introduction and Business Overview
    Table 129. Beijing AMSINO Drug Eluting Implant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Beijing AMSINO Drug Eluting Implant Product Offerings
    Table 131. Beijing AMSINO Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Drug Eluting Implant Downstream Customers
    Table 135. Drug Eluting Implant Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drug Eluting Implant Product Picture
    Figure 2. Global Drug Eluting Implant Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Drug Eluting Implant Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Drug Eluting Implant Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Drug Eluting Implant Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Drug Eluting Implant Report Years Considered
    Figure 7. Global Drug Eluting Implant Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Drug Eluting Implant Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Drug Eluting Implant Revenue in 2023
    Figure 10. Drug Eluting Implant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Rapamycin Eluting Implant Picture
    Figure 12. Paclitaxel Eluting Implant Picture
    Figure 13. Everolimus Eluting Implant Picture
    Figure 14. Others Picture
    Figure 15. Global Drug Eluting Implant Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Drug Eluting Implant Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Drug Eluting Implant Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Drug Eluting Implant Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Drug Eluting Implant Price by Type (2019-2030) & (US$/Unit)
    Figure 20. Product Picture of Hospitals
    Figure 21. Product Picture of Clinics
    Figure 22. Product Picture of Ambulatory Surgical Centers
    Figure 23. Product Picture of Others
    Figure 24. Global Drug Eluting Implant Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Drug Eluting Implant Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Drug Eluting Implant Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 27. Global Drug Eluting Implant Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Drug Eluting Implant Price by Application (2019-2030) & (US$/Unit)
    Figure 29. North America Drug Eluting Implant Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Drug Eluting Implant Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Drug Eluting Implant Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Drug Eluting Implant Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Drug Eluting Implant Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Drug Eluting Implant Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Drug Eluting Implant Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Drug Eluting Implant Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Drug Eluting Implant Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Drug Eluting Implant Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Drug Eluting Implant Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Drug Eluting Implant Sales Volume (%), (2019-2030)
    Figure 41. United States Drug Eluting Implant Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Drug Eluting Implant Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Drug Eluting Implant Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Drug Eluting Implant Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Drug Eluting Implant Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Drug Eluting Implant Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Drug Eluting Implant Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Drug Eluting Implant Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Drug Eluting Implant Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Drug Eluting Implant Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Drug Eluting Implant Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Drug Eluting Implant Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Drug Eluting Implant Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Drug Eluting Implant Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Drug Eluting Implant Sales Value by Application (%), 2023 VS 2030
    Figure 62. Drug Eluting Implant Industrial Chain
    Figure 63. Drug Eluting Implant Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global AI-Powered Pathology Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33C18563
Wed Dec 11 00:00:00 UTC 2024

Add to Cart

Add to Cart

Global Healthcare Laboratory Information System Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37O18687
Wed Dec 11 00:00:00 UTC 2024

Add to Cart

Sterile Hypodermic Single Use Syringe - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-20D14836
Mon Dec 09 00:00:00 UTC 2024

Add to Cart